A viral vaccine vector that expresses foreign genes in lymph nodes and protects against mucosal challenge

No abstract is available for this paper.

• Publication year

  1996

• Venue

  Journal of Virology

• Publication date

  1996-06-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1128/jvi.70.6.3781-3787.1996PMID 8648713PMCID PMC190254
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Mucosal immunity induced by parenteral immunization with a live attenuated Venezuelan equine encephalitis virus vaccine candidate.

  1997cited by this paper
• Specific restrictions in the progression of Venezuelan equine encephalitis virus-induced disease resulting from single amino acid changes in the glycoproteins.

  1995influential reference
• Mechanism of neuroinvasion of Venezuelan equine encephalitis virus in the mouse.

  1995cited by this paper
• Attenuated mutants of Venezuelan equine encephalitis virus containing lethal mutations in the PE2 cleavage signal combined with a second-site suppressor mutation in E1.

  1995cited by this paper
• 29 – Mucosal Immunity to Viruses

  1994cited by this paper
• Intracellular immunization of mosquito cells to LaCrosse virus using a recombinant Sindbis virus vector.

  1994cited by this paper
• The alphaviruses: gene expression, replication, and evolution

  1994cited by this paper
• Self-replicating Semliki Forest virus RNA as recombinant vaccine.

  1994cited by this paper
• Chimeric influenza virus induces neutralizing antibodies and cytotoxic T cells against human immunodeficiency virus type 1

  1993cited by this paper
• Rubella virus-specific cytotoxic T-lymphocyte responses: identification of the capsid as a target of major histocompatibility complex class I-restricted lysis and definition of two epitopes

  1993cited by this paper
• The efficient intracellular sequestration of the insulin-regulatable glucose transporter (GLUT-4) is conferred by the NH2 terminus

  1992cited by this paper
• Infectious enveloped RNA virus antigenic chimeras.

  1992cited by this paper
• Infectious Sindbis virus transient expression vectors for studying antigen processing and presentation.

  1992cited by this paper
• A New Generation of Animal Cell Expression Vectors Based on the Semliki Forest Virus Replicon

  1991cited by this paper
• In vitro mutagenesis of a full-length cDNA clone of Semliki Forest virus: the small 6,000-molecular-weight membrane protein modulates virus release

  1991cited by this paper
• Pathogenesis of Venezuelan Equine Encephalitis Virus Infection in Mice and Hamsters

  1991cited by this paper
• Attenuating mutations in the E2 glycoprotein gene of Venezuelan equine encephalitis virus: construction of single and multiple mutants in a full-length cDNA clone.

  1991influential reference
• Promoter for Sindbis virus RNA-dependent subgenomic RNA transcription

  1990cited by this paper
• In vitro synthesis of infectious venezuelan equine encephalitis virus RNA from a cDNA clone: analysis of a viable deletion mutant.

  1989cited by this paper
• Sindbis virus: an efficient, broad host range vector for gene expression in animal cells.

  1989cited by this paper
• Antigen chimaeras of poliovirus as potential new vaccines

  1988cited by this paper
• Recombinant vaccinia virus/Venezuelan equine encephalitis (VEE) virus protects mice from peripheral VEE virus challenge

  1988cited by this paper
• Adaptor plasmids simplify the insertion of foreign DNA into helper-independent retroviral vectors

  1987cited by this paper
• Characterization of Sindbis virus epitopes important for penetration in cell culture and pathogenesis in animals.

  1986cited by this paper
• Rapid and efficient site-specific mutagenesis without phenotypic selection.

  1985cited by this paper
• Protective efficacies of live attenuated and formaldehyde-inactivated Venezuelan equine encephalitis virus vaccines against aerosol challenge in hamsters

  1984cited by this paper
• Live recombinant vaccinia virus protects chimpanzees against hepatitis B

  1984cited by this paper
• Generation of antibody diversity in the immune response of BALB/c mice to influenza virus hemagglutinin. I. Significant variation in repertoire expression between individual mice

  1983cited by this paper
• Outcome of influenza infection: effect of site of initial infection and heterotypic immunity.

  1980influential reference
• Serum antibody prevents lethal murine influenza pneumonitis but not tracheitis

  1979cited by this paper
• Persistence in humans of antibody to subtypes of Venezuelan equine encephalomyelitis (VEE) virus after immunization with attenuated (TC-83) VEE virus vaccine.

  1977cited by this paper
• The comparative pathology of experimental Venezuelan equine encephalomyelitis infection in different animal hosts.

  1962cited by this paper

• Fc-mediated pan-sarbecovirus protection after alphavirus vector vaccination

  2023cites this paper
• A roadmap for developing Venezuelan equine encephalitis virus (VEEV) vaccines: Lessons from the past, strategies for the future.

  2023cites this paper
• Alphavirus-based vaccines.

  2020cites this paper
• University of Groningen Immunotherapy based on influenza virosomes and recombinant Semliki Forest virus

  2017influential citation
• United States Patent Hennecke

  2017cites this paper
• Immunogenicity and efficacy of alphavirus-derived replicon vaccines for respiratory syncytial virus and human metapneumovirus in nonhuman primates.

  2016cites this paper
• Anti-tumor effect of the alphavirus-based virus-like particle vector expressing prostate-specific antigen in a HLA-DR transgenic mouse model of prostate cancer.

  2015cites this paper
• FMD Vaccine Surge Capacity for Emergency Use in the United States

  2014cites this paper
• Novel Technologies for Vaccine Development

  2014cites this paper
• An Alphavirus-Based Adjuvant Enhances Serum and Mucosal Antibodies, T Cells, and Protective Immunity to Influenza Virus in Neonatal Mice

  2014cites this paper
• Characterization of alphavirus replicon particle based vaccines and adjuvants in a neonatal murine model

  2014cites this paper
• Alphavirus Replicon Vectors for Prophylactic Applications and Cancer Intervention

  2014cites this paper
• An Alphavirus-based Adjuvant Enhances Serum and Mucosal Antibodies, T cells and Protective 2

  2014cites this paper
• in Neonatal Mice and Protective Immunity to Influenza Virus Serum and Mucosal Antibodies , T Cells , An Alphavirus-Based Adjuvant Enhances

  2014cites this paper
• Differentiation of stem and progenitor cells from bone marrow in activated dendritic cells and lymphocytes with anti-malignant properties

  2013cites this paper
• Venezuelan Equine Encephalitis Virus Replicon Particle Vaccine Protects Nonhuman Primates from Intramuscular and Aerosol Challenge with Ebolavirus

  2013cites this paper
• A hemagglutinin-esterase-expressing salmonid alphavirus replicon protects Atlantic salmon (Salmo salar) against infectious salmon anemia (ISA).

  2013cites this paper
• Virus-like Particle Vaccines for Norovirus Gastroenteritis

  2013cites this paper
• Viral Vectors for Gene Transfer

  2012cites this paper
• A Novel Self-Replicating Chimeric Lentivirus-Like Particle

  2011cites this paper
• Vaccines for Gonorrhea: Can We Rise to the Challenge?

  2011cites this paper
• A novel neurotropic expression vector based on the avirulent A7(74) strain of Semliki Forest virus

  2011influential citation
• Development of candidate vaccine strategies against Rift Valley Fever virus

  2011cites this paper
• HIV Vaccines

  2011cites this paper
• Progress towards development of an HIV vaccine: report of the AIDS Vaccine 2009 Conference.

  2010cites this paper
• Viral shape-shifting: norovirus evasion of the human immune system

  2010cites this paper
• Gene Therapy with Plasmid DNA

  2010cites this paper
• Induction of neutralizing antibodies to Hendra and Nipah glycoproteins using a Venezuelan equine encephalitis virus in vivo expression system.

  2010cites this paper
• The route of inoculation determines the tissue tropism of modified vaccinia tiantan expressing the spike glycoprotein of SARS‐CoV in mice†, ‡

  2010cites this paper
• Alphavirus replicon-based enhancement of mucosal and systemic immunity is linked to the innate response generated by primary immunization.

  2010cites this paper
• Ebola and Marburg

  2009cites this paper
• Recombinant Vectors as Influenza Vaccines

  2009cites this paper
• Gene and Virotherapy Against Osteosarcoma

  2009cites this paper
• Sindbis virus vectors elicit hemagglutinin-specific humoral and cellular immune responses and offer a dose-sparing strategy for vaccination.

  2008cites this paper
• Development of Improved Dengue 2 Antigen Configurations for a Venezuelan Equine Encephalitis Virus Replicon Particle-Launched Dengue Vaccine

  2008cites this paper
• Systemic neutralizing antibodies induced by long interval mucosally primed systemically boosted immunization correlate with protection from mucosal SHIV challenge.

  2008cites this paper
• Nonviral Genetic Vaccines for Cancer

  2007cites this paper
• Venezuelan Equine Encephalitis Virus Replicon Particles Encoding Respiratory Syncytial Virus Surface Glycoproteins Induce Protective Mucosal Responses in Mice and Cotton Rats

  2007cites this paper
• Mice and Cotton Rats Induce Protective Mucosal Responses in Syncytial Virus Surface Glycoproteins Replicon Particles Encoding Respiratory Venezuelan Equine Encephalitis Virus

  2007cites this paper
• Studies on the immunogenicity in swine of influenza A virus hemagglutinin expressed by Venezuelan equine encephalitis virus-like replicon particles

  2007cites this paper
• Viral Alteration of Cellular Translational Machinery Increases Defective Ribosomal Products

  2007cites this paper
• Nuclear Import and Export of Venezuelan Equine Encephalitis Virus Nonstructural Protein 2

  2007cites this paper
• Venezuelan equine encephalitis virus nonstructural protein 2 in the host cell

  2007influential citation
• Toward Viral Vaccine Development: A Modified Venezuelan Equine Encephalitis Replicon as Strategy for Optimizing Immunogenicity

  2007cites this paper
• Recombinant alphaviruses as vectors for anti-tumour and anti-microbial immunotherapy.

  2006cites this paper
• Ribosomal Protein S6 Associates with Alphavirus Nonstructural Protein 2 and Mediates Expression from Alphavirus Messages

  2006cites this paper
• Vector System: Plasmid DNA

  2006cites this paper
• Chapter 57 – Recombinant Live Viral Vectors as Vaccines for Mucosal Immunity

  2005cites this paper
• Poly ([beta]-amino ester)s as pH sensitive biomaterials for microparticulate genetic vaccine delivery

  2005cites this paper
• Vaccination of macaques with SIV immunogens delivered by Venezuelan equine encephalitis virus replicon particle vectors followed by a mucosal challenge with SIVsmE660.

  2005cites this paper
• Protection of Rhesus Monkeys against Infection with Minimally Pathogenic Simian-Human Immunodeficiency Virus: Correlations with Neutralizing Antibodies and Cytotoxic T Cells

  2005cites this paper
• The immune response to equine arteritis virus: potential lessons for other arteriviruses.

  2004cites this paper
• Alphaviral-Based Strategies for the Immunotherapy of Cancer

  2004cites this paper
• Future vaccines against emerging encephalitides.

  2004cites this paper
• Alphaviruses and their derived vectors as anti-tumor agents.

  2004cites this paper
• Mucosal immunity

  2004cites this paper
• The author hereby certifies that the use of copyrighted material in the thesis manuscript entitled:

  2003influential citation
• Evaluation of Venezuelan Equine Encephalitis (VEE) replicon-based Outer surface protein A (OspA) vaccines in a tick challenge mouse model of Lyme disease.

  2003cites this paper
• Induction of Primary Virus-Cross-Reactive Human Immunodeficiency Virus Type 1-Neutralizing Antibodies in Small Animals by Using an Alphavirus-Derived In Vivo Expression System

  2003cites this paper
• HIV vaccine development: lessons from the past and promise for the future.

  2003cites this paper
• Transfection-independent production of alphavirus replicon particles based on poxvirus expression vectors

  2003cites this paper
• A Vaccine for Gonorrhea

  2003cites this paper
• Plasmid DNA–Mediated Gene Therapy

  2003cites this paper
• Evaluation of FIV protein-expressing VEE-replicon vaccine vectors in cats.

  2002cites this paper
• Immunologic control of HIV-1.

  2002cites this paper
• Alphavirus replicon particles expressing the two major envelope proteins of equine arteritis virus induce high level protection against challenge with virulent virus in vaccinated horses.

  2002cites this paper
• Alphavirus vectors and vaccination

  2002influential citation
• Systemic, Mucosal, and Heterotypic Immune Induction in Mice Inoculated with Venezuelan Equine Encephalitis Replicons Expressing Norwalk Virus-Like Particles

  2002cites this paper
• Expression and Self-Assembly of Norwalk Virus Capsid Protein from Venezuelan Equine Encephalitis Virus Replicons

  2002cites this paper
• Herpes Simplex Virus Vectors Elicit Durable Immune Responses in the Presence of Preexisting Host Immunity

  2002cites this paper
• Alphavirus vectors: development and potential therapeutic applications

  2001cites this paper
• Construction and characterization of recombinant vaccinia viruses co-expressing a respiratory syncytial virus protein and a cytokine.

  2001cites this paper
• Vaccine potential of Ebola virus VP24, VP30, VP35, and VP40 proteins.

  2001cites this paper
• Innovations in oral gene delivery: challenges and potentials.

  2001cites this paper
• Influenza Virus

  2001cites this paper
• Sindbis virus-based vectors for the study of class I antigen presentation in vitro and in vivo.

  2001cites this paper
• Candidate Vaccine against Botulinum Neurotoxin Serotype A Derived from a Venezuelan Equine Encephalitis Virus Vector System

  2001cites this paper
• Individual and Bivalent Vaccines Based on Alphavirus Replicons Protect Guinea Pigs against Infection with Lassa and Ebola Viruses

  2001cites this paper
• Alphavirus Vectors: Applications for DNA Vaccine Production and Gene Expression

  2001cites this paper
• Role of Alpha/Beta Interferon in Venezuelan Equine Encephalitis Virus Pathogenesis: Effect of an Attenuating Mutation in the 5′ Untranslated Region

  2001cites this paper
• NOVEL STRATEGIES TOWARD THE DEVELOPMENT OF AN EFFECTIVE VACCINE TO PREVENT HUMAN IMMUNODEFICIENCY VIRUS INFECTION OR ACQUIRED IMMUNODEFICIENCY VIRUS*

  2001cites this paper
• Role of Dendritic Cell Targeting in Venezuelan Equine Encephalitis Virus Pathogenesis

  2000cites this paper
• A Single Amino Acid Change in nsP1 Attenuates Neurovirulence of the Sindbis-Group Alphavirus S.A.AR86

  2000cites this paper
• Vaccine Development for Hepatitis C

  2000cites this paper
• Recombinant RNA replicons derived from attenuated Venezuelan equine encephalitis virus protect guinea pigs and mice from Ebola hemorrhagic fever virus.

  2000cites this paper
• Delivery Systems for Gene-based Vaccines

  2000cites this paper
• Cell Engineering

  2000cites this paper
• Maintenance of CD8(+) T-cell memory following infection with recombinant sindbis and vaccinia viruses.

  2000cites this paper
• Expression of the Two Major Envelope Proteins of Equine Arteritis Virus as a Heterodimer Is Necessary for Induction of Neutralizing Antibodies in Mice Immunized with Recombinant Venezuelan Equine Encephalitis Virus Replicon Particles

  2000cites this paper
• Alphavirus expression vectors.

  2000cites this paper
• Alphavirus Vectors: Highly Efficient Systems for Transient Gene Expression

  2000cites this paper
• RNA viruses: emerging vectors for vaccination and gene therapy.

  2000cites this paper
• Replicon-based vectors of positive strand RNA viruses.

  2000cites this paper
• Vaccination of Macaques against Pathogenic Simian Immunodeficiency Virus with Venezuelan Equine Encephalitis Virus Replicon Particles

  2000cites this paper
• Venezuelan equine encephalitis virus vectors expressing HIV-1 proteins: vector design strategies for improved vaccine efficacy.

  1999cites this paper
• Attenuated Vesicular Stomatitis Viruses as Vaccine Vectors

  1999influential citation
• Induction of P815 tumor immunity by recombinant Semliki Forest virus expressing the P1A gene

  1999cites this paper
• Recombinant viruses as vectors for mucosal immunity.

  1999cites this paper
• Alphavirus vectors for gene expression and vaccines.

  1999cites this paper
• Production of recombinant subunit vaccines: protein immunogens, live delivery systems and nucleic acid vaccines.

  1999cites this paper